[Durgical](https://durgical.com/en/) › [DurgiPedia](https://durgical.com/en/durgipedia/) › [Obstetrics and gynaecology](https://durgical.com/en/obstetrics-gynaecology/) › [Menopause and the pelvic floor](https://durgical.com/en/obstetrics-gynaecology/areas/menopause/) › Osteoporosis after menopause

# Osteoporosis after menopause

- Routine care

Bone is lost fastest in the years after [menopause](https://durgical.com/en/physiology/menopause/). A hip fracture can end an older woman's independence, and treatment prevents many fractures.

Updated Nov 15, 2026

**See it in 3D:** [Hip bone](https://durgical.com/en/anatomy/hip-bone/) · [Sacrum](https://durgical.com/en/anatomy/sacrum/)

## Key points

- [T-score](https://durgical.com/en/endocrinology/osteoporosis-dxa-t-score-versus-z-score-and-fracture-risk/) −2.5 or lower, or a hip or spine fragility fracture = [osteoporosis](https://durgical.com/en/conditions/osteoporosis/).
- [Bisphosphonates](https://durgical.com/en/pharmacology/classes/bisphosphonates/) first line; oral ones fasting and upright.
- Never stop [denosumab](https://durgical.com/en/pharmacology/denosumab/) without a follow-on bisphosphonate.
- Rule out secondary causes and correct [vitamin D](https://durgical.com/en/biochemistry/molecules/vitamin-d/) before treatment.
- Treat after any fragility fracture and prevent falls.

On this page

- The basics Key points
- What it is
- How to think about it
- What it looks for
- How it is done
- The medicines compared
- Common mistakes
- Next step / When to refer
- Common traps
- Elsewhere in DurgiPedia

- Study Test yourself

- Connections Connections

## What it is

Osteoporosis is low bone mass with damaged bone architecture, which makes bones break with little force (fragility fractures) at the spine, hip, wrist and upper arm. It is diagnosed by a bone density scan (DXA) showing a T-score of −2.5 or lower at the hip or spine, or by a fragility fracture of the hip or spine whatever the scan shows; a T-score between −1 and −2.5 is low bone mass (osteopenia). After menopause, falling oestrogen speeds bone breakdown. Care combines fracture-risk assessment (such as FRAX), a search for secondary causes, lifestyle and [fall prevention](https://durgical.com/en/nursing/preventing-falls-risk-assessment-and-measures/), calcium and vitamin D, and medicines: bisphosphonates first line, denosumab, [raloxifene](https://durgical.com/en/pharmacology/raloxifene/) or hormone therapy in selected women, and bone-building drugs ([teriparatide](https://durgical.com/en/pharmacology/teriparatide/), [romosozumab](https://durgical.com/en/pharmacology/romosozumab/)) for very high risk.

## How to think about it

Bone is a bank with two tellers: [osteoblasts](https://durgical.com/en/physiology/bone-remodeling/) make deposits, osteoclasts make withdrawals. Oestrogen keeps the withdrawing teller in check. At menopause the check goes, and for several years withdrawals outpace deposits, mostly from the spongy bone of the spine. Drugs work on one teller or the other: antiresorptives slow withdrawals (bisphosphonates, denosumab, raloxifene, hormone therapy), anabolics hire more depositors (teriparatide, romosozumab). Denosumab is a brake that must never be released suddenly.

## What it looks for

- Assess every woman from 65, and younger postmenopausal women with risk factors: earlier fragility fracture, [glucocorticoids](https://durgical.com/en/physiology/actions-of-cortisol/), low body weight, smoking, heavy alcohol use, a parent with hip fracture, [rheumatoid arthritis](https://durgical.com/en/conditions/rheumatoid-arthritis/), early menopause.
- DXA at the hip and spine: T-score −2.5 or lower = osteoporosis; between −1 and −2.5 = low bone mass.
- A fragility fracture of the hip or spine diagnoses osteoporosis even with a normal scan.
- FRAX combines risk factors (with or without DXA) into a ten-year fracture probability, which guides treatment in low bone mass.
- Secondary causes to look for: [vitamin D deficiency](https://durgical.com/en/endocrinology/vitamin-d-whom-to-test-and-what-the-result-means/), hyperparathyroidism, hyperthyroidism, [coeliac disease](https://durgical.com/en/conditions/coeliac-disease/), kidney disease, myeloma and medicines such as glucocorticoids and [aromatase inhibitors](https://durgical.com/en/pharmacology/classes/aromatase-inhibitors/).

## How it is done

- Ask about earlier fractures, height loss, back pain, falls and risk factors; measure height.
- Order DXA when indicated and calculate fracture risk (FRAX).
- Check for secondary causes with blood tests before treating.
- Advise for everyone: weight-bearing and balance exercise, enough calcium and vitamin D in food, no smoking, limited alcohol.
- Make the home safe and review medicines that cause falls (sedatives, some antihypertensives).
- Offer a medicine when osteoporosis is diagnosed or fracture risk is high, choosing by risk and kidney function.
- Review adherence and side effects; reassess after about three to five years of a bisphosphonate to decide on a pause.

## The medicines compared

| Medicine | How it works | Best for | Key cautions |
| --- | --- | --- | --- |
| [Bisphosphonates (alendronic acid orally, zoledronic acid by infusion)](https://durgical.com/en/conditions/osteoporosis/) | Bind bone and switch off osteoclasts | First line for most women | Oral: fasting, upright, with water; avoid in oesophageal disease and poor kidney function; rare jaw [osteonecrosis](https://durgical.com/en/general-pathology/osteonecrosis/) and atypical [femur](https://durgical.com/en/anatomy/femur/) fractures |
| Denosumab | Antibody against RANKL; stops osteoclast formation | Kidney impairment, or bisphosphonate not tolerated | Never stop without a follow-on bisphosphonate: rebound vertebral fractures |
| Raloxifene | Oestrogen-like on bone, anti-oestrogen on breast | Spine risk, with [breast cancer](https://durgical.com/en/conditions/breast-cancer/) risk | Venous clots, [hot flushes](https://durgical.com/en/obstetrics-gynaecology/menopause-symptoms-hormone-therapy-and-long-term-health/); no hip fracture benefit shown |
| [Hormone therapy](https://durgical.com/en/conditions/menopause-and-climacteric-syndrome/) | Replaces oestrogen | Women under 60 with menopausal symptoms | The usual hormone therapy contraindications |
| [Teriparatide, romosozumab](https://durgical.com/en/conditions/osteoporotic-vertebral-compression-fracture/) | Build new bone | Very high risk, several vertebral fractures | Specialist use; follow with an antiresorptive; romosozumab: cardiovascular caution |

## Common mistakes

- Oestrogen falls → more RANKL and osteoclast activity → spongy bone is lost faster than it is rebuilt → thin trabeculae → vertebral fractures → height loss, kyphosis and back pain.
- Missing the treatment gap: many women leave hospital after a hip or vertebral fracture without bone treatment, the strongest predictor of the next fracture.
- Before intravenous [zoledronic acid](https://durgical.com/en/pharmacology/zoledronic-acid/) or denosumab, correct low vitamin D and calcium, or severe [hypocalcaemia](https://durgical.com/en/conditions/hypocalcaemia/) can follow.
- Check the mouth and finish urgent dental work before antiresorptives when possible; jaw osteonecrosis is rare but more likely after extractions.
- New thigh or groin pain on long-term bisphosphonates can be an atypical femoral fracture: image both femurs.

## Next step / When to refer

- Before treating: calcium, phosphate, [creatinine](https://durgical.com/en/biochemistry/molecules/creatinine/), vitamin D, [liver](https://durgical.com/en/anatomy/liver/) tests, TSH and a blood count; PTH if calcium is abnormal, and tests for myeloma or coeliac disease when suggested.
- Spine X-ray when there is height loss or back pain, as silent vertebral fractures change the risk.
- Refer to a specialist: fractures despite treatment, very low T-scores, several vertebral fractures, kidney failure, premenopausal women, or a secondary cause.
- After a fragility fracture: start treatment and arrange fall prevention before discharge.

## Common traps

- **A normal DXA rules out osteoporosis in a woman with a vertebral fragility fracture**: the fracture itself makes the diagnosis and calls for treatment.
- **Calcium and vitamin D alone treat osteoporosis**: they support the drugs but do not prevent enough fractures on their own.
- **Denosumab can be stopped like a bisphosphonate**: its effect fades within months and bone breakdown rebounds, causing multiple vertebral fractures, so a bisphosphonate must follow.
- **The T-score is used in premenopausal women too**: in younger women a Z-score compared with women of the same age is used, and a low value points to a secondary cause.

## Test yourself

Think of the answer, then tap the question to see it.

## A 68-year-old has a vertebral fracture after lifting a pot. Her DXA T-score is −2.1. Does she have osteoporosis?

Yes. A fragility fracture of the spine diagnoses osteoporosis whatever the T-score, and she should be offered treatment.

## Why must denosumab not simply be stopped?

Its effect wears off within months and bone breakdown rebounds, causing rapid bone loss and multiple vertebral fractures; a bisphosphonate is given to follow it.

## Why does bone loss speed up after menopause?

Oestrogen normally restrains osteoclasts; without it, RANKL-driven bone breakdown outpaces formation, especially in spongy bone of the spine.

## What must be checked before starting intravenous zoledronic acid?

Kidney function, calcium and vitamin D: deficiency must be corrected first to avoid severe hypocalcaemia, and poor kidney function rules it out.

[Add to my cards (4)](https://durgical.app/estudiar/?add=/en/obstetrics-gynaecology/osteoporosis-after-menopause/)

## Elsewhere in DurgiPedia

- [Osteoporosis](https://durgical.com/en/general-pathology/osteoporosis/)
- [Menopause](https://durgical.com/en/physiology/menopause/)
- [Menopause: symptoms, self-care, bone and heart health, and what to teach about hormone therapy](https://durgical.com/en/nursing/menopause-symptoms-self-care-bone-and-heart-health-and-what-to-teach-about-hormo/)

## Connections

## See it in 3D 2

The structures of Durgical's 3D anatomy where it is found.

- [Hip bone](https://durgical.com/en/anatomy/hip-bone/)
- [Sacrum](https://durgical.com/en/anatomy/sacrum/)

## Related 3

- [Menopause: symptoms, hormone therapy and long-term health](https://durgical.com/en/obstetrics-gynaecology/menopause-symptoms-hormone-therapy-and-long-term-health/)
- [Premature ovarian insufficiency](https://durgical.com/en/obstetrics-gynaecology/premature-ovarian-insufficiency/)
- [Breast cancer screening in Colombia](https://durgical.com/en/obstetrics-gynaecology/breast-cancer-screening-in-colombia/)

## Related conditions 4

- [Osteoporosis](https://durgical.com/en/conditions/osteoporosis/)
- [Osteoporotic vertebral compression fracture](https://durgical.com/en/conditions/osteoporotic-vertebral-compression-fracture/)
- [Femoral Neck Fracture](https://durgical.com/en/conditions/femoral-neck-fracture/)
- [Menopause and climacteric syndrome](https://durgical.com/en/conditions/menopause-and-climacteric-syndrome/)

## In Pharmacology 8

- [Bisphosphonates](https://durgical.com/en/pharmacology/classes/bisphosphonates/)
- [Alendronic acid (alendronate)](https://durgical.com/en/pharmacology/alendronic-acid/)
- [Zoledronic acid](https://durgical.com/en/pharmacology/zoledronic-acid/)
- [Denosumab](https://durgical.com/en/pharmacology/denosumab/)
- [Raloxifene](https://durgical.com/en/pharmacology/raloxifene/)
- [Teriparatide](https://durgical.com/en/pharmacology/teriparatide/)
- [Romosozumab](https://durgical.com/en/pharmacology/romosozumab/)
- [Calcium carbonate](https://durgical.com/en/pharmacology/calcium-carbonate/)

[← All of obstetrics and gynaecology](https://durgical.com/en/obstetrics-gynaecology/)

Educational content; it does not replace assessment by a doctor or your institution's protocols, and it contains no doses. For heavy bleeding, a severe headache or blurred vision, a seizure, fever, strong abdominal pain or fewer baby movements, go to an emergency department at once.

Sources: [Osteoporosis in Females](https://www.ncbi.nlm.nih.gov/books/NBK559156/) (StatPearls Publishing (NCBI Bookshelf), 2025); [Bisphosphonate](https://www.ncbi.nlm.nih.gov/books/NBK470248/) (StatPearls Publishing (NCBI Bookshelf), 2023); [Consensus statement: osteoporosis prevention and treatment in Latin America-current structure and future directions](https://europepmc.org/article/PMC/PMC6132387) (Archives of osteoporosis (Europe PMC), 2018); [Menopause (fact sheet)](https://www.who.int/news-room/fact-sheets/detail/menopause) (World Health Organization, 2024).

## **Spotted a mistake?** We are always improving for the community. Tell us what is wrong and our team will review it. Report a mistake

Representative model, for educational purposes only.

---
Source: https://durgical.com/en/obstetrics-gynaecology/osteoporosis-after-menopause/
License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Cite as: DurgiPedia (durgical.com), https://durgical.com/en/obstetrics-gynaecology/osteoporosis-after-menopause/
